Aspire Biopharma to effect 1-for-30 reverse stock split

Aspire Biopharma (ASBP) will effect a one-for-thirty reverse stock split of its common stock, par value $0.0001 per share, that will become effective on May 11, 2026, at 12:01 AM Eastern Time, before the opening of trading on The Nasdaq Capital Market. Aspire has requested that its Common Stock begin trading on May 11, 2026, on a post-reverse split basis on the Nasdaq under the existing symbol “ASBP”. The reverse split is primarily intended to bring Aspire into compliance with the minimum bid price requirement for maintaining its listing on the Nasdaq. The new CUSIP number for the Common Stock following the reverse split will be 738920305.